p53-dependent apoptosis pathways

被引:348
作者
Shen, Y
White, E [1 ]
机构
[1] Howard Hughes Med Inst, Piscataway, NJ 08854 USA
[2] Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
[3] Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA
[4] Dept Cell & Dev Biol, Piscataway, NJ 08854 USA
[5] Canc Inst New Jersey, Piscataway, NJ 08854 USA
[6] Rutgers State Univ, Piscataway, NJ 08854 USA
来源
ADVANCES IN CANCER RESEARCH, VOL 82 | 2001年 / 82卷
关键词
D O I
10.1016/S0065-230X(01)82002-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p53 tumor suppressor limits cellular proliferation by inducing cell cycle arrest and apoptosis in response to cellular stresses such as DNA damage, hypoxia, and oncogene activation. Many apoptosis-related genes that are transcriptionally regulated by p53 have been identified. These are candidates for implementing p53 effector functions. In response to oncogene activation, p53 mediates apoptosis through a linear pathway involving bax transactivation, Bax translocation from the cytosol to membranes, cytochrome c release from mitochondria, and caspase-9 activation, followed by the activation of caspase-3, -6, and -7. p53-mediated apoptosis can be blocked at multiple death checkpoints, by inhibiting p53 activity directly, by Bcl-2 family members regulating mitochondrial function, by E1B 19K blocking caspase-9 activation, and by caspase inhibitors. Understanding the mechanisms by which p53 induces apoptosis, and the reasons why cell death is bypassed in transformed cells, is of fundamental importance in cancer research, and has great implications in the design of anticancer therapeutics. © 2001 Academic Press.
引用
收藏
页码:55 / +
页数:33
相关论文
共 252 条
  • [1] Spodoptera frugiperda caspase-1, a novel insect death protease that cleaves the nuclear immunophilin FKBP46, is the target of the baculovirus antiapoptotic protein p35
    Ahmad, M
    Srinivasula, SM
    Wang, LJ
    Litwack, G
    FernandesAlnemri, T
    Alnemri, ES
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) : 1421 - 1424
  • [2] Li-Fraumeni syndrome and the role of the p53 tumor suppressor gene in cancer susceptibility
    Akashi, M
    Koeffler, HP
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 1998, 41 (01) : 172 - 199
  • [3] Human ICE/CED-3 protease nomenclature
    Alnemri, ES
    Livingston, DJ
    Nicholson, DW
    Salvesen, G
    Thornberry, NA
    Wong, WW
    Yuan, JY
    [J]. CELL, 1996, 87 (02) : 171 - 171
  • [4] ALNEMRI ES, 1992, CANCER RES, V52, P491
  • [5] Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice
    Amson, R
    Lassalle, JM
    Halley, H
    Prieur, S
    Lethrosne, F
    Roperch, JP
    Israeli, D
    Gendron, MC
    Duyckaerts, C
    Checler, F
    Dausset, J
    Cohen, D
    Oren, M
    Telerman, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5346 - 5350
  • [6] Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria
    Antonsson, B
    Montessuit, S
    Lauper, S
    Eskes, R
    Martinou, JC
    [J]. BIOCHEMICAL JOURNAL, 2000, 345 : 271 - 278
  • [7] Inhibition of Bax channel-forming activity by Bcl-2
    Antonsson, B
    Conti, F
    Ciavatta, A
    Montessuit, S
    Lewis, S
    Martinou, I
    Bernasconi, L
    Bernard, A
    Mermod, JJ
    Mazzei, G
    Maundrell, K
    Gambale, F
    Sadoul, R
    Martinou, JC
    [J]. SCIENCE, 1997, 277 (5324) : 370 - 372
  • [8] Attardi LD, 2000, GENE DEV, V14, P704
  • [9] p53 inhibits α6β4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB
    Bachelder, RE
    Ribick, MJ
    Marchetti, A
    Falcioni, R
    Soddu, S
    Davis, KR
    Mercurio, AM
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 147 (05) : 1063 - 1072
  • [10] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915